Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.
Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1743-1752. doi: 10.26355/eurrev_202203_28244.
This study aimed to investigate whether the lactate-to-albumin ratio (LAR) can predict mortality in patients with sepsis or septic shock.
A systematic search of the PubMed, EMBASE, Web of Science, and Google Scholar databases was conducted on December 16, 2021, for relevant articles that provided the predictive performance of LAR for mortality in patients with sepsis or septic shock.
Eight studies encompassing a total of 4,723 patients were included in this paper. The pooled sensitivity, specificity, and diagnostic odds ratio of the LAR for predicting mortality were 0.71 (95% confidence interval [CI]: 0.54-0.84), 0.68 (95% CI: 0.58-0.76) and 5.23 (95% CI: 2.62-10.45), respectively. The area under the summary receiver operating characteristic curve was 0.74 (95% CI: 0.70-0.78).
The current evidence suggests that LAR is moderately predictive of mortality among patients with sepsis or septic shock and may be beneficial to identify high-risk patients.
本研究旨在探讨乳酸与白蛋白比值(LAR)能否预测脓毒症或脓毒性休克患者的死亡率。
我们于 2021 年 12 月 16 日在 PubMed、EMBASE、Web of Science 和 Google Scholar 数据库中进行了系统性检索,以查找提供 LAR 对脓毒症或脓毒性休克患者死亡率预测性能的相关文章。
本文纳入了 8 项共纳入 4723 例患者的研究。LAR 预测死亡率的汇总敏感度、特异度和诊断比值比分别为 0.71(95%置信区间[CI]:0.54-0.84)、0.68(95% CI:0.58-0.76)和 5.23(95% CI:2.62-10.45)。汇总受试者工作特征曲线下面积为 0.74(95% CI:0.70-0.78)。
目前的证据表明,LAR 对脓毒症或脓毒性休克患者的死亡率具有中等程度的预测价值,可能有助于识别高危患者。